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OBJECTIVES We contrasted various methods for assessing ventricular pressure decay time constants to test
whether sensitivity to slight data instability or disparities between model-assumed and real
decay are systematically altered by cardiac failure. We hypothesized that such discrepancies
could result in apparent increased relaxation sensitivity to load and drug stimulation.
BACKGROUND Deviation of relaxation behavior from model-assumed waveforms may be worsened by failure,
enhancing instability and apparent load and drug sensitivity of commonly used indexes.
METHODS Pressure-volume relations were measured in patients with normal (n 5 14), hypertrophic
(hypertrophic cardiomyopathy [HCM], n 5 15) and dilated-myopathic (dilated cardiomy-
opathy [DCM], n 5 37) hearts before and during preload reduction or inotropic stimulation.
Relaxation parameters (monoexponential [ME] model assuming zero-Tln or non-zero-TD,
TF asymptote:, hybrid logistic-TL, linear-TLR, and pressure halftime-T1/2) were contrasted
regarding sensitivity to slight data range manipulation and loading or drug changes.
RESULTS In DCM, TD and TF prolonged 15% to 25% (p , 0.0001) by deletion of only 1–2 data points,
whereas this had minimal effect on controls or HCM. This stemmed from systematic
deviation of relaxation from an ME decay in DCM. T1/2 and Tln were highly sensitive to pure
pressure offsets, whereas TL was most stable to both manipulations in all hearts. As a result,
TD and TF appeared to be much more sensitive to systolic load in DCM than T1/2 or TL and
disproportionately sensitive to increased cyclic adenosine monophosphate (cAMP).
CONCLUSIONS Relaxation consistently deviates from an ME decay in DCM resulting in instability and
amplified relaxation systolic load or drug dependence of ME-based indexes in failing versus
control (or HCM) hearts. The hybrid-logistic method improves quantitative analyses by
providing more consistent data fits with all three heart types. (J Am Coll Cardiol 1999;34:
1529–36) © 1999 by the American College of Cardiology
Delay of ventricular pressure decline plays an important role
in the pathophysiology of hypertrophic cardiomyopathy
(HCM) and dilated cardiomyopathy (DCM) (1–4). In
addition to baseline delay, relaxation is further slowed by
increased systolic loading (5,6), an effect reportedly en-
hanced by heart failure (7). Quantitation of pressure decline
in normal and failing hearts is generally based on model fits
to the decay waveform, with monoexponentials (MEs)
being most common (8,9). Alternative models have been
proposed, including biexponentials (10), linear fits (11) and
a hybrid-logistic (HL) fit (12,13). However, pressure decay
does not necessarily follow any of these waveforms (14), and
systematic discrepancies between real and assumed pressure
decay for healthy versus diseased hearts could potentially
affect quantitative disparities in relaxation load dependence
or drug sensitivity. This means that a seemingly arbitrary
choice of relaxation model might yield very different results
from such interventions.
Ideally, an index of pressure decline should be sensitive to
underlying relaxation behavior, yet be fairly insensitive to
slight noise in the portion of data from which it is derived
or to pure pressure offsets. Such minor data fluctuations are
almost inevitable when relaxation is assessed in vivo. Pa-
rameters derived from curve fits that closely follow both
pressure decay and its first derivative are more likely to
satisfy these criteria. Accordingly, the goal of this study was
two-fold. First, we sought to contrast widely used relaxation
indexes with respect to these criteria, testing for systematic
discrepancies when comparing normal to failing hearts.
Second, we tested the hypothesis that apparent systolic-load
and pharmacologic influences on pressure relaxation criti-
cally depend on the index used—particularly in heart failure,
due largely to such systematic discrepancies. Our study finds
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that the HL model (12,13) provides the most consistent fit
to pressure decay in healthy and diseased hearts, thereby
conferring practical advantages for quantitative relaxation
analyses.
METHODS
Sixty-six adult patients referred for diagnostic cardiac cath-
eterization were studied. Fourteen had normal ventricular
function, without coronary artery, valvular or other identi-
fied cardiac disease. Fifteen had nonobstructive HCM with
an average wall thickness of 1.6 6 0.25 cm. Nonobstructive
HCM was chosen because other forms of the disease pose
recognized difficulties for relaxation-decay analysis due to
the abrupt release of obstruction during pressure decline
(15). The remaining patients had DCM from ischemic (n 5
5) or nonischemic (n 5 32) etiologies. Age ranged from 38
to 80 years (mean 56). All patients provided informed
consent, and the protocol was approved by The Johns
Hopkins Joint Committee on Clinical Investigation.
Procedures. Patients were premedicated with benzodiaz-
epam (5 to 10 mg) and diphenhydramine (25 to 50 mg).
After routine coronary angiography, left ventriculography
and right heart catheterization, left ventricular (LV) pres-
sure and volume were measured by the volume catheter
method (SPC-562/7, 562/4, Millar) (15). Data were ob-
tained at rest and during transient preload reduction in-
duced by transient obstruction of inferior vena caval inflow.
The latter maneuver also yielded data testing the influence
of varying end-systolic pressures on relaxation time con-
stants. In 26 DCM patients, data were also obtained after
intravenous (IV) dobutamine (5 mg/kg/min, n 5 19) or
toborinone (5 to 10 mg/kg/min, n 5 7). The latter is a
quinolinone derivative that increases contractility and has-
tens relaxation (16).
Data analysis. Data were digitally recorded at 200 Hz
using custom acquisition-display software. Left ventricular
pressure decay analysis was based on data spanning the point
at minimal first derivative of pressure (dP/dtmin) to
2 mm Hg above end-diastolic pressure (EDP). dP/dt was
determined by digital filter, while EDP was defined as the
pressure when dP/dt reached a threshold of 10% of maxi-
mum.
Six pressure relaxation assessments were calculated. Pres-
sure half time (T1/2) was the time required for pressure at
dP/dtmin to decline 50%. Monoexponential-based tau was
calculated assuming pressure decayed to a zero (Tln) or
non-zero (TD and TF) asymptote. Tln was the negative
reciprocal of the linear slope relating the natural logarithm
of pressure to time (8). TD was calculated from regression of
pressure versus dP/dt (9), whereas TF was determined by
non-linear regression (Marquardt), using: P(t) 5
(Po2P‘)e
2t/TF 1 P‘, where P‘ is the pressure decay
asymptote, and Po is near the pressure at dP/dtmin. A
(HL)-based tau (TL) was determined from the equation
P(t) 5 2(Po92P9‘)/(11e
t/T) 1 P‘9 (12). Finally, pressure-
time data were fit by linear regression, and the inverse
negative slope (TLR) was used to index decay rate.
The sensitivity of each index to slight alterations in the
input data was tested two ways. First, the lower pressure
cutoff value was varied from EDP 1 2 to EDP 1
10 mm Hg. This cutoff is somewhat arbitrary in practice,
being designed to restrict analysis to isovolumic data.
Second, LV pressures were shifted 25 or 210 mm Hg (as
might accompany inspiration) without altering the wave-
form. The sensitivity of each index to disease condition was
determined from rest data in each group.
The implication of differences in index behavior deter-
mined in the first part of the study were then tested with
Abbreviations and Acronyms
ANOVA 5 analysis of variance
cAMP 5 cyclic adenosine monophosphate
DCM 5 dilated cardiomyopathy
EDP 5 end-diastolic pressure
Ees 5 end-systolic elastance
HCM 5 hypertrophic cardiomyopathy
HL 5 hybrid-logistic
LV 5 left ventricle or ventricular
ME 5 monoexponential
Pes 5 end-systolic pressure








Ees (mm Hg/ml) 2.36 6 0.36 4.88 6 1.86 1.17 6 0.18*†
EF (%) 63.9 6 4.5 66.2 6 3.6 25.0 6 3.4*†
ESP (mm Hg) 127.9 6 6.7 159.9 6 9.0* 126.0 6 4.9†
EDV (ml) 114.5 6 12.3 101.7 6 6.6 299.2 6 27.5*†
EDP (mm Hg) 11.3 6 1.7 17.5 6 1.9* 20.6 6 1.3*
T1/2 (ms) 25.9 6 1.1 33.6 6 1.4* 41.3 6 1.8*†
Tln (ms) 37.9 6 2.8 43.9 6 1.8* 56.2 6 1.8*†
TD (ms) 44.3 6 3.0 71.6 6 6.3* 101.6 6 8.1*†
TF (ms) 45.8 6 3.2 69.4 607.4* 108.6 6 8.6*†
TL (ms) 20.9 6 1.2 27.9 6 2.4* 34.9 6 1.6*†
TLR (ms/mm Hg) 0.96 6 0.04 1.10 6 0.10* 1.37 6 0.07*†
P‘ (mm Hg)
ME 213.0 6 1.8 223.6 6 7.4 236.8 6 5.4*
HL 2.0 6 2.6 5.9 6 3.6 3.9 6 1.9
Po (mm Hg)
ME 75.9 6 2.9 88.3 6 4.7 75.1 6 3.7
HL 76.1 6 2.9 87.5 6 4.7 73.5 6 3.8
*p , 0.05 vs. Normal; †p , 0.05 vs. HCM by ANOVA.
ANOVA 5 analysis of variance; Ees 5 end-systolic elastance; EF 5 ejection
fraction; ESP 5 end-systolic pressure; EDV 5 end-diastolic volume; EDP 5
end-diastolic pressure; HCM 5 hypertrophic cardiomyopathy; HL 5 hybrid-logistic;
ME 5 mono-exponential; T1/2 5 pressure half-time; Tln, TD, TF 5 time constants
of pressure decay based on ME model; TL 5 based on HL model (see Methods
section for details). TLR 5 inverse linear slope of the pressure-time data; P‘ 5
pressure asymptote from nonlinear fits; Po 5 pressure at onset of relaxation from
non-linear fits.
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respect to the quantitative analysis of load and drug effects.
To test the extent to which altered load sensitivity of
relaxation in DCM depended on the decay analysis used,
relations between tau and end-systolic pressure were gener-
ated from data recorded during vena caval occlusion. Rela-
tion slopes were plotted versus contractile state indexed by
end-systolic elastance (Ees) (15) or dP/dtmax for each heart.
Tau responses to dobutamine/toborinone (16) were also
contrasted.
Results are presented as mean 6 SEM, with resting
differences between groups tested by analysis of variance
(ANOVA). Sensitivity of tau parameters to data range or
pressure offset manipulation were tested by a two-way
repeated measures ANOVA, with the patient serving as the
second categorical variable.
RESULTS
Baseline hemodynamics. Table 1 summarizes hemody-
namics data in each group. Data for ischemic and nonisch-
emic DCM are combined since they were statistically
indistinguishable. All pressure relaxation indexes yielded
qualitatively similar results, with decay prolongation in
HCM patients and even longer time courses in DCM.
However, there were substantial quantitative differences,
with DCM being between 142% to 1137% longer than
controls depending upon the index used. TD and TF yielded
the largest differences and TLR and Tln the smallest. Both
ME and HL models yielded two additional fit parameters,
Po and P‘, and there were substantial differences in the
latter between models. P‘, or the estimated pressure decay
asymptote, was negative in all patient groups with the ME
model and was considerably so (237 6 5.4 mm Hg) in
DCM. In contrast, P‘ was small, positive and did not
significantly change between disease states with the HL
model. Po—or the pressure at the onset of relaxation—was
similar from both models in each respective group.
Responses to small data range manipulation and pressure
offsets. Figure 1 displays results of input data range and
offset sensitivity testing. Data are shown as percent change
for each index as a function of a given manipulation,
normalized to the basal condition. Top panels show the
effects of varying the lower pressure cutoff point (i.e.,
EDP 1 2, EDP 1 6) typically altering the analysis by one
or two data points. In normal and HCM hearts, varying this
cutoff pressure had little quantitative effect. TLR, however,
shortened .10% with this maneuver in controls. In con-
Figure 1. Comparative sensitivity of pressure-decay assessments (see Methods section for definitions of parameters) to small variations in
the input data. Upper panels display the consequence of varying the lower pressure cut-off point from 2 to 10 mm Hg above end-diastolic
pressure (EDP). Lower panels display the effects from a pure downward offset displacement of the LV pressure data (LVP) by 0 to
210 mm Hg. Data are displayed as mean percent change (6SEM) relative to a reference state (leftward condition in each plot). * p ,
0.05 versus reference, based on RMANOVA (repeated measures analysis of variance).
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trast, TD and TF were quite sensitive to this change in
DCM, prolonging nearly 25 msec (20%, p , 0.0001).
Smaller but consistent rises were also observed in Tln (p ,
0.0001). In contrast, TL shortened relatively little (;1 ms,
or 5%) in each heart type. T1/2 was unaltered by this change
by its definition.
The lower panels display the effects of shifting the
pressure data by an absolute offset. As predicted from their
definitions, TD, TF, TL and TLR were unaltered by this
manipulation. However, Tln and T1/2 significantly and
substantially shortened as much as 25%;30% in all heart
types (p , 0.0001) by varying the offset. Thus, the index
that consistently displayed the least change to slight alter-
ations in the input data range or pressure offset was TL.
Comparison of model fits. One explanation for the dis-
parity in behavior of ME versus HL models related to their
goodness-of-fit. The more accurate the fit, the better it
described not only the time course of pressure decline but
also the instantaneous rate of decline. Pressure-time plots
were equally well fit by ME or HL models in all groups
(Fig. 2, top); however, there were substantial discrepancies
in the capacity of each model to predict the local slope
(dP/dt) of pressure fall (Fig. 2, middle). In DCM patients,
the ME fit (dashed line) failed to describe the dP/dt course,
whereas the HL fit predicted the derivative well. Similar
results were observed in control and HCM patients.
When dP/dt is plotted versus P (Fig. 2, lower panels), a
pure ME decay process appears as a line. While each heart
type deviated from a linear relation, the greatest discrepancy
occurred systematically with DCM. P-dP/dt nonlinearity
was significant (p , 0.05 for quadratic term) in 57% of
control subjects, 73% of HCM and 91% of DMC (p , 0.05
Figure 2. Pressure-time (upper panels), dP/dt-time (middle panels) and dP/dt-P plots (lower panels) from representative beats in
normal, HCM and DCM hearts. Monoexponential fits are shown by dashed lines and logistic fit by solid lines in each instance. P(t) data
were well fit in all instances by both models. However, in DCM patients, the ME model did not predict dP/dt data well, and in all cases
the logistic model better predicted this derivative. The lower plots synthesize these two behaviors, with ME fits appearing as a straight
line, and logistic fits as a parabola. The latter better approximated the measured data—most notably in DCM ventricles. DCM 5 dilated
cardiomyopathy; HCM 5 hypertrophic cardiomyopathy; ME 5 monoexponential.
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by Chi-square analysis). The corresponding sum-of-squares
errors for ME models were 17%, 70% and 469% higher than
with HL fits (p , 0.001). Furthermore, because the
ME-decay model fit a line to P-dP/dt relations, the linear
slope (negative inverse is TD) was very sensitive to deletion
of even a single data point if the real P-dP/dt data were
nonlinear (e.g., DCM). The more linear the dP/dt-P plot
(e.g., control subjects), the less ME tau varied from this
maneuver. The HL model fit nonlinear P(t) and dP/dt data
more consistently in all heart types.
Contractility and relaxation-load dependence: influence
of index selection. Prior studies using ME-based pressure
relaxation analysis have shown that prolongation of decay
time with increasing end-systolic pressure is exacerbated as
contractility falls (5–7). However, our observation that
pressure decline deviated more from an ME waveform in
DCM than it did in control hearts suggested that a
substantial component of this behavior might be method-
ologically based. To test this, we regressed relations between
the percent change in relaxation index for a given percent
change in end-systolic pressure (Pes) from multiple cycles
(Table 2). Again, there was qualitative agreement in that all
of the indexes indicated some systolic load dependence of
relaxation. However, quantitative differences were striking.
For all ME-based indexes (Tln TF and TD), the results
suggested a .4-fold increase in load sensitivity in DCM
hearts versus controls. In contrast, T1/2 and TL slopes were
smaller, and differences between DCM and controls were
not statistically significant. TLR relation slopes yielded the
complete opposite effect, i.e., TLR increased with reduced
load.
Figures 3A and B display plots of tau-Pes relation slopes
versus cardiac contractility for each patient, using TD and
TF, respectively. These data demonstrate a hyperbolic de-
pendence, similar to that previously reported (5,7). Figure
3C shows the same plot using dP/dtmax as the contractile
index, demonstrating that the choice of Ees was not critical
to this result. However, when either TL or T1/2 were used,
the results suggested minimal change in load sensitivity with
varying contractility (Fig. 3D and E). Thus, the observation
of greater load dependence of tau at reduced contractility
was itself critically dependent on the precise method chosen
to assess pressure decay. To further test if the hyperbolic
relation shown in panels A–C of Figure 3 primarily reflected
the extent to which pressure decay waveform deviated from
an ME model at reduced contractility, we calculated differ-
ences in sum-of-squares error for linear versus nonlinear fits
to dP/dt-P plots. The greater the difference, the more the
deviation from the ME decay. Substitution of this difference
as the ordinate, instead of tau load-dependence, yielded
results (Fig. 3F) similar to the hyperbolic relations in Figure
3A–C.
Pharmacologic stimulation. Another consequence of sys-
tematically greater deviation from a ME-decay in DCM is
that pharmacologic agents altering this disparity can dispro-
portionately influence tau indexes based on ME models.
Both dobutamine and toborinone elevate cyclic adenosine
monophosphate (cAMP), enhancing ejection and improv-
ing relaxation. The net effect was a transition to a more ME
decay, demonstrated by increasing linearity of P-dP/dt
relations (the SS-error was 410% higher for ME vs. HL
model fits before drug, and 170% higher after drug [p ,
0.05]). As a result, ME-based indexes exhibited signifi-
cantly greater absolute and percent tau reduction (20% to
24%) with drug (Table 3). In contrast, the HL equation fit
pre- and post-drug data similarly, and TL was shortened by
10%. A similar discrepancy was observed with TLR (linear
fit) which also shortened half as much as ME indexes,
whereas T1/2 declined similarly as ME indexes.
DISCUSSION
This study reports two major findings. First, systematic
deviation of relaxation in DCM from an ME waveform
increases the sensitivity of ME-based time constants to
small changes in input data. Furthermore, this deviation
greatly enhances apparent load sensitivity of ME indexes
with worsening failure and amplifies responses to pharma-
cologic change. Simply substituting alternative indexes such
as T1/2 or TL, a seemingly arbitrary choice, yields very
different magnitudes of response, particularly with respect to
changes in relaxation-load sensitivity. Second, TL derived
from an HL model consistently provides the least variability
with small changes in the input or pure pressure offsets and
better fits the time course of pressure decay and its first
derivative (particularly in DCM). These are attractive fea-
tures for clinical applications, because they reduce method-
ologic bias when comparing data between normal and
depressed hearts and reduce data noise from uncertainties in
absolute LV pressure (i.e., influence of external constraints
or EDPS).
Relaxation analysis assumptions and comparative perfor-
mance. Whereas previous studies have examined pitfalls of
relaxation indexes, this is the first to systematically compare
tau sensitivity with small variance in the input data in
Table 2. Load-Sensitivity of Various Time Constants
of Relaxation
Normal HCM DCM
T1/2 0.37 6 0.15 0.44 6 0.17 0.76 6 0.11
Tln 0.28 6 0.13 0.51 6 0.13 0.88 6 0.11*
TD 0.43 6 0.21 0.45 6 0.20 1.71 6 0.21*†
TF 0.42 6 0.23 0.43 6 0.21 1.75 6 0.22*†
TL 0.20 6 0.18 0.19 6 0.20 0.44 6 0.08
TLR 21.38 6 0.20 21.30 6 0.24 21.10 6 0.17
Data are mean regression slopes (dimensionless) for relations between percent change
in tau versus percent change in end-systolic pressure for each index in the three patient
groups.
*p , 0.05 vs. normal; †p , 0.05 vs. HCM by ANOVA.
ANOVA 5 analysis of variance; DCM 5 dilated cardiomyopathy; HCM 5
hypertrophic cardiomyopathy.
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diseased and normal human hearts. By using the natural
logarithm of pressure, Tln diminishes noise, but it is sensi-
tive to pure offset pressures (17) by forcing pressure to
decline to zero. TF and TD circumvent this limitation but
display greater sensitivity to small alterations in the data
range used for analysis in DCM hearts. The lower cutoff
pressure is often arbitrarily set to EDP 1 5 mm Hg, with
the goal being to assure that the data fall within the
isovolumetric period. The finding that only a few mm Hg
difference in this cutoff in DCM can have marked effects on
ME-tau quantitation is a nontrivial limitation, because
there is frequently ambiguity as to the exact value of EDP
from pressure data (particularly in DCM hearts), and small
beat-to-beat fluctuations can change this value. Finally,
differences in this effect among normal and HCM hearts
can amplify apparent differences in response to interventions
when comparisons are made to DCM.
Three non-ME based indexes were also tested. Of these,
Figure 3. Relations between relaxation load sensitivity and contractility. (A) TD-Pes slope versus Ees. The data define a hyperbolic
relation, with apparent increasing load dependence of tau at low contractility. (B) The same relation derived using TF . (C) A similar
relation employing resting dP/dtmax as the index of contractile function, rather than Ees. This shows that the dependence did not require
a specific contractility analysis parameter. (D) The same relation determined using TL. These results are markedly different from those in
panels A–C, with virtually no change in the load-sensitivity despite varying Ees. (E) The same analysis employing T1/2, again showing
how a simple change in the assessment method of relaxation markedly altered the appearance of enhanced load-dependence in depressed
hearts. (F) A similar analysis, in which the SSD for ME versus logistic models is substitute for a tau-Pes slope ordinate. The plot is similar
to panels A–C, showing that the major cause for apparent hyperbolic dependence in the latter is due to the enhanced deviation from a
ME-relaxation decay with declining Ees. Ees 5 end-systolic elastance; ME 5 monoexponential; SSD 5 sum of the squares.
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TL provided the least sensitivity to small changes in data
range and pressure offsets. The primary reason for this was
that the HL model yielded the most consistent fit to P and
dP/dt data. Pressure decay results from an interaction of
crossbridge relaxation, elastic recoil and geometric configu-
rational change, so it is difficult if not impossible to explain
the improved fit of the HL model on crossbridge mechan-
ics. Nonetheless, our data clearly demonstrated improved
fits particularly in DCM ventricles, which should assist
analysis of pressure decay in this disease.
The key difference between ME and HL goodness-of-fit
was not evident by their ability to fit P(t) data but in their
predictive accuracy to the pressure derivative and thus
P-dP/dt plots. In normal human hearts such data appear
near-linear. However, in isolated, denervated canine hearts
(12) and failing human hearts, such plots reveal consistent
(.90% of subjects) convex nonlinearity. Under these con-
ditions, elimination of even one data point yields very
different ME tau. An alternative approach is to employ a
biexponential model, fitting upper and lower portions of the
nonlinear P-dP/dt plot to two separate lines (10). This
enhances fit stability, but does not resolve other issues—
such as the markedly increased load-sensitivity. The HL
model better fits both pressure-time and dP/dt data, and
this assists consistency of characterization in both control
and DCM hearts.
Implications for loading and drug effects. Recent studies
have reported reduced inotropic response to adrenergic
stimulation in DCM despite apparent preservation of
relaxation-shortening (18,19). To date, a precise cellular or
molecular explanation for this disparity has remained un-
clear. However, these observations were based on ME and
T1/2 analyses, and the current study shows such indexes can
yield larger proportional changes in tau due to changes in
offset pressures or decay waveform shape. This suggests
caution when a more quantitative analysis is applied using
ME-derived parameters in DCM.
Eichhorn et al. (7) reported that slopes of relations
between TD and Pes increased as systolic function (Ees)
declined. Ishizaka et al. (20) reported similar findings using
TD in conscious dogs with tachycardia-induced DCM. Had
either investigator used TL or T1/2, a seemingly arbitrary
choice from the standpoint of relaxation analysis, this
behavior would not have been observed. Our results do not
refute studies showing greater tau load-dependence at high
afterload in hearts with depressed contractility (5,6). How-
ever as found by Gillebert et al. (6), this load dependence is
very nonlinear, with minimal effects at normal or reduced
loads, consistent with our results using TL or T1/2.
It should be noted that there is no real in vivo standard
with which to compare any of these indexes of pressure
relaxation. As a result, one might argue that indexes such as
TL or T1/2 are simply underestimating real load or drug
effects. However, these differences were principally related
to an improved goodness-of-fit with the HL model, which
implies greater robustness rather than artifactual error to the
measurements.
Conclusions. Assessment of diastolic function by rate of
pressure decline based on commonly used ME tau or T1/2
can be influenced by varying discrepancies between real and
model-assumed decay behavior. This can result in system-
atic bias when quantifying and comparing systolic load and
drug-induced effects between normal or HCM to DCM.
An alternative fit based on an HL equation appears to
minimize these factors, providing a sensitive but more
robust assessment of pressure decay in DCM.
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